SCHEMBL20168253

SCHEMBL20168253

CC(C)C(c1ccno1)n1cc(-c2ccc(Cl)cc2)c2c(N)ncnc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.53
TEK Q02763 10/20 0.53
LCK P06239 8/20 0.53
SRC P12931 6/20 0.53
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CB P42338 1/20 0.44
PIK3CG P48736 1/20 0.44
PRKDC P78527 1/20 0.44
RET P07949 3/20 0.44
FLT3 P36888 1/20 0.42
ABL1 P00519 2/20 0.41
EGFR P00533 2/20 0.41
ABL2 P42684 1/20 0.41
DAPK3 O43293 1/20 0.40
RIPK2 O43353 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
YES1 P07947 1/20 0.40
LYN P07948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020100 0.81 KDR (0.68) KDRTEKLCKSRCPIK3CD
SCHEMBL20162806 0.77 KDR (0.58) KDRTEKLCKSRCPIK3CD
SCHEMBL30037235 0.77 KDR (0.58) KDRTEKLCKSRCPIK3CD
SCHEMBL13020096 0.72 SRC (0.69) KDRTEKLCKSRCFLT3
SCHEMBL20162651 0.72 KDR (0.46) KDRTEKLCKSRCPIK3CD
SCHEMBL30037546 0.72 KDR (0.46) KDRTEKLCKSRCPIK3CD
SCHEMBL30538106 0.72 KDR (0.46) KDRTEKLCKSRCPIK3CD
SCHEMBL20162649 0.72 KDR (0.46) KDRTEKLCKSRCPIK3CD
SCHEMBL7007567 0.71 KDR (0.71) KDRTEKLCKSRCPIK3CD
SCHEMBL20162934 0.71 PIK3CD (0.46) KDRTEKLCKSRCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541390-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS Cystic Fibrosis Foundation Therapeutics Inc. (US) 2019-09-25 EP disclosed
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed